Your search for "data access" matched 49 page(s).
Showing results 1 to 10.
 Report on the EMA Workshop on clinical trial data and transparency
					 - Volume 22, Issue
				Report on the EMA Workshop on clinical trial data and transparency
					 - Volume 22, Issue 
			
		Access to patient data gathered in clinical trials is a highly controversial and complex issue that needs to balance three aspects: the public right to transparency regarding data used to approve new medicines, protection of the data privacy rights…
 Navigating the EMA clinical data website
					 - Volume 27, Issue
				Navigating the EMA clinical data website
					 - Volume 27, Issue 
			
		This paper describes how to register, access, and navigate the EMA clinical data website. One of the authors (RB) is a medical writer and accessed the site from the perspective of a pharmaceutical industry professional. The other author (AS) is not…
 MyData: Applying human-centric principles to health data
					 - Volume 29, Issue
				MyData: Applying human-centric principles to health data
					 - Volume 29, Issue 
			
		Modern data legislation increasingly empowers citizens, and therefore patients, with rights to access and control their health data. The mechanisms needed to exercise modern data rights are currently underdeveloped and underserving individuals and…
 How FAIR are pharma publication data?
					 - Volume 31, Issue
				How FAIR are pharma publication data?
					 - Volume 31, Issue 
			
		Sharing research data increases reusability, reduces waste, supports reproducibility and promotes innovation. In medical research, sharing data also promotes transparency and access to information relevant to patient care. While important…
 Implications of clinical trial data sharing for medical writers
					 - Volume 22, Issue
				Implications of clinical trial data sharing for medical writers
					 - Volume 22, Issue 
			
		Major clinical research funders are increasingly adopting policies supporting or mandating data sharing. These moves should improve the transparency and availability of clinical trial data and are likely to impact the work and responsibilities of…
 The new value of clinical data in Europe
					 - Volume 29, Issue
				The new value of clinical data in Europe
					 - Volume 29, Issue 
			
		The EU’s new Medical Devices Regulation and In-vitro Diagnostic Device Regulation has integrated and reinforced the regulatory requirements for pre- and post-market clinical trials and positioned them as vital to ensuring the safety and performance…
 Unlocking the potential of patient data through responsible sharing – has anyone seen my keys?
					 - Volume 29, Issue
				Unlocking the potential of patient data through responsible sharing – has anyone seen my keys?
					 - Volume 29, Issue 
			
		The sharing of individual participant-level clinical data is now an almost routine extension of the clinical study life-cycle, and increasingly a vital element of leveraging real-word data. Responsible clinical study data sharing of appropriately…
 Systematic hospital collection of patient-reported outcome data via patient apps
					 - Volume 27, Issue
				Systematic hospital collection of patient-reported outcome data via patient apps
					 - Volume 27, Issue 
			
		Medical writers are increasingly likely to come across patient apps in their work, and we describe here the background and use of two apps for assessing patient-reported outcome (PRO). Systematic collection of PRO data via patient apps has been…
 Enhancing accessibility of study data: The development of a graphical abstract for lay summaries of clinical trial results
					 - Volume 29, Issue
				Enhancing accessibility of study data: The development of a graphical abstract for lay summaries of clinical trial results
					 - Volume 29, Issue 
			
		We describe the development of a graphical abstract for lay summaries of clinical trial results. The new graphical summary serves the same purpose for a lay summary as an abstract does for a scientific publication. Lay summaries are intended to…
 Overview of the European General Data Protection Regulation (GDPR) impact on medical writing  for clinical trials
					 - Volume 32, Issue
				Overview of the European General Data Protection Regulation (GDPR) impact on medical writing  for clinical trials
					 - Volume 32, Issue 
			
		The European General Data Protection Regulation 2016/ 679 (GDPR) aims to ensure the security and privacy of individuals in the European Union (EU). Companies located within and outside of the EU must comply with GDPR when processing personal data…
Medical Writing is a quarterly publication that aims to educate and inform medical writers in Europe and beyond. Each issue focuses on a specific theme, and all issues include feature articles and regular columns on topics relevant to the practice of medical writing. We welcome articles providing practical advice to medical writers; guidelines and reviews/summaries/updates of guidelines published elsewhere; original research; opinion pieces; interviews; and review articles.
Medical Writing is listed in the following indexes:
Editor-in-Chief
Co-Editors
Senior Editor
Victoria White
Managing Editor
Alicia Brooks Waltman
Associate Editors
Section Editors
AI/Automation
Biotechnology
Digital Communication
EMWA News
Freelancing
Gained in Translation
Getting Your Foot in the Door
Good Writing Practice
Pablo Izquierdo / Alison McIntosh
In the Bookstores
Publications
Medical Communications/Writing for Patients
Medical Devices
My First Medical Writing
News from the EMA
Pharmacovigilance
Regulatory Matters
Regulatory Public Disclosure
Louisa Ludwig-Begall / Sarah Kabani
The Crofter: Sustainable Communications
Veterinary Writing
Editors Emeritus
Layout Designer
Chris Monk